PFE Pfizer Inc. Stock Quote

PFE [NYSE]

Healthcare | Drug Manufacturers - General | USA

Index	S&P 500	P/E	11.64	EPS (ttm)	4.43	Insider Own	0.04%	Shs Outstand	5.62B	Perf Week	-0.46%
Market Cap	290.41B	Forward P/E	9.42	EPS next Y	5.48	Insider Trans	-5.77%	Shs Float	5.61B	Perf Month	-1.97%
Income	25.42B	PEG	-	EPS next Q	1.90	Inst Own	69.20%	Short Float	1.37%	Perf Quarter	0.14%
Sales	92.37B	P/S	3.14	EPS this Y	233.60%	Inst Trans	0.62%	Short Ratio	3.15	Perf Half Y	-12.55%
Book/sh	14.67	P/B	3.52	EPS next Y	-19.24%	ROA	14.00%	Target Price	58.62	Perf Year	29.98%
Cash/sh	4.25	P/C	12.15	EPS next 5Y	-0.80%	ROE	32.70%	52W Range	38.93 - 61.71	Perf YTD	-12.55%
Dividend	1.60	P/FCF	12.64	EPS past 5Y	27.40%	ROI	18.90%	52W High	-15.54%	Beta	0.72
Dividend %	3.10%	Quick Ratio	1.10	Sales past 5Y	9.00%	Gross Margin	60.40%	52W Low	33.88%	ATR	1.45
Employees	79000	Current Ratio	1.40	Sales Q/Q	76.80%	Oper. Margin	30.30%	RSI (14)	55.58	Volatility	2.66% 2.70%
Optionable	Yes	Debt/Eq	0.44	EPS Q/Q	58.80%	Profit Margin	27.00%	Rel Volume	0.59	Prev Close	51.64
Shortable	Yes	LT Debt/Eq	0.43	Earnings	Jul 28 BMO	Payout	35.30%	Avg Volume	24.41M	Price	52.12
Recom	2.30	SMA20	3.26%	SMA50	2.91%	SMA200	3.33%	Volume	10,763,112	Change	0.93%

May-23-22

Initiated

SVB Leerink

Mkt Perform

$55

Apr-06-22

Resumed

Morgan Stanley

Equal-Weight

$55

Jan-05-22

Upgrade

BofA Securities

Neutral → Buy

$59 → $70

Jan-03-22

Reiterated

Bernstein

Mkt Perform

$44 → $65

Dec-20-21

Reiterated

Cowen

Outperform

$56 → $70

Dec-17-21

Initiated

Goldman

Neutral

$51

Dec-13-21

Upgrade

UBS

Neutral → Buy

$52 → $60

Dec-09-21

Initiated

Wells Fargo

Overweight

$60

Nov-19-21

Initiated

BMO Capital Markets

Outperform

$60

Jul-27-21

Resumed

Truist

Buy

$43

May-06-21

Downgrade

Mizuho

Buy → Neutral

$42

Apr-07-21

Resumed

RBC Capital Mkts

Sector Perform

$42

Feb-04-21

Upgrade

DZ Bank

Hold → Buy

$41

Dec-16-20

Downgrade

RBC Capital Mkts

Outperform → Sector Perform

$43 → $42

Nov-19-20

Resumed

Goldman

Neutral

$40

Nov-10-20

Resumed

Bernstein

Mkt Perform

$42

Oct-12-20

Downgrade

Atlantic Equities

Overweight → Neutral

$44 → $39

Sep-29-20

Initiated

Berenberg

Hold

$38

Jun-16-20

Initiated

SVB Leerink

Mkt Perform

$40

Feb-27-20

Upgrade

Standpoint Research

Hold → Buy

Jul-06-22 01:01PM	UPDATE 1-U.S. FDA allows pharmacists to prescribe Pfizer's COVID pill Reuters
10:52AM	COVID-19 subvariants may evade vaccine protection, giant snails pose health risk in Florida Yahoo Finance Video
09:47AM	Pfizer Dives As CureVac Tees Up A Patent Suit Aimed At Its BioNTech-Partnered Covid Shot Investor's Business Daily
08:01AM	Millions of AstraZeneca vaccines binned because no country wants them The Telegraph
07:00AM	Covid-19 Vaccine Doses, Once in High Demand, Now Thrown Away The Wall Street Journal
06:52AM	This Inflation Spike May Be Ending. Thats Good for Cathie Wood. Barrons.com
06:20AM	Should You Invest in the iShares U.S. Healthcare ETF (IYH)? Zacks
06:00AM	This May Be Pfizer's Key to Long-Term Vaccine Dominance Motley Fool
03:00AM	Sarepta Wants to Speed Up Approval of Its Gene Therapy. What It Means for the Stock. Barrons.com
Jul-05-22 05:45PM	Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know Zacks
03:36PM	Is Pfizer Stock A Buy Or A Sell As Its Covid Vaccine Faces A New Lawsuit? Investor's Business Daily
12:33PM	CureVac Sues BioNTech Over mRNA and Covid Vaccines. Pfizer Stock Isnt Spared. Barrons.com
11:09AM	Exelixis (EXEL) Outperforms Industry in 1H22: What Lies Ahead? Zacks
09:28AM	The BA.5 Omicron Wave Is Rising. What It Means for Your Next Booster. Barrons.com
09:24AM	CureVac Files COVID-19 Vaccine Patent Infringement Lawsuit Against BioNTech Benzinga
07:35AM	BioNTech stock falls after CureVac files suit, saying COVID vaccine infringes patents MarketWatch
06:36AM	The Zacks Analyst Blog Highlights Pfizer, BioNTec and Moderna Zacks
Jul-03-22 10:50AM	German health minister in move to boost use of COVID treatment Paxlovid Reuters
Jul-02-22 11:09AM	How mRNA tech blew open the door of UPS's cold chain logistics business Yahoo Finance
Jul-01-22 10:56AM	Pfizer (PFE) Seeks FDA Nod for Its Oral Antiviral COVID Pill Zacks
09:45AM	FDA Recommends Adding New Omicron Subvariants to COVID Boosters Zacks
09:00AM	Is Trending Stock Pfizer Inc. (PFE) a Buy Now? Zacks
08:24AM	FDA Expert Panel Favors COVID-19 Boosters Targeting Omicron BA.4, BA.5 Subvariants Benzinga
06:57AM	The Zacks Analyst Blog Highlights Sanofi, Merck, Novartis, Pfizer and J&J Zacks
Jun-30-22 06:58PM	Why Pfizer Popped While the Market Flopped Today Motley Fool
05:34PM	RPT-UPDATE 4-US FDA wants COVID boosters targeting Omicron BA.4, BA.5 subvariants Reuters
04:10PM	The FDA Just Handed BioNTech And Moderna A Gift But Only One Jumped Investor's Business Daily
03:51PM	FDA backs adjusting COVID booster to new variants, RH and TSM stocks down Yahoo Finance Video
03:47PM	FDA Wants Fall Covid-19 Boosters to Target Omicron Subvariants BA.4 and BA.5 The Wall Street Journal
03:24PM	Omicron: Experts want more data to guide US targeting of fall boosters Yahoo Finance
02:24PM	This Analyst Says US Government Buying More COVID-19 Vaccines At Higher Prices Benzinga
02:22PM	COVID SCIENCE-Pausing methotrexate improves booster response; first-trimester of pregnancy vaccination most beneficial Reuters
01:45PM	FDA Asks Vaccine Makers for Boosters to Target BA.5 Barrons.com
01:36PM	UPDATE 1-Pfizer asks for formal U.S. approval of oral COVID treatment Paxlovid Reuters
12:49PM	Pfizer Seeks Complete Approval For Paxlovid For High Risk COVID-19 Patients Benzinga
12:42PM	Why BioNTech Stock Advanced Today Motley Fool
12:37PM	Is AbbVie Stock A Buy As Humira Biosimilar Rivals Loom? Investor's Business Daily
11:41AM	Supreme Court Allows New York Vaccine Mandate for Health-Care Workers Bloomberg
11:30AM	Is Pfizer Stock a Buy Now? Motley Fool
10:49AM	FDA says COVID-19 boosters should be updated to combat two omicron subvariants MarketWatch
10:03AM	Pfizer (PFE) Inks Deal With US Government for COVID Jab Supply Zacks
09:38AM	Pfizer Stock Jumps On $3.2 Billion U.S. Covid Vaccine Sale, FDA Paxlovid Approval Filing TheStreet.com
09:25AM	Billionaire Ray Dalio is Shorting These 10 European Stocks Insider Monkey
09:04AM	Pfizer Raises Covid Vaccine Price 27%. What It Means for the Stock. Barrons.com
08:46AM	Pharma Stock Roundup: FDA Panel Backs Updated COVID Jabs, EU Nod for SNY, MRK Drugs Zacks
07:38AM	The Chef's Warehouse and AZEK have been highlighted as Zacks Bull and Bear of the Day Zacks
07:36AM	US Government Calls For Additional Doses Of Pfizer/BioNTech COVID-19 Vaccine Benzinga
06:56AM	Pfizer submits a new NDA to FDA for COVID-19 pill PAXLOVID MarketWatch
06:45AM	Pfizer Seeks FDAs Full Approval for Paxlovid Covid-19 Pill The Wall Street Journal
06:45AM	Pfizer asks for formal U.S. approval of oral COVID treatment Paxlovid Reuters
06:45AM	Pfizer Announces Submission of New Drug Application to the U.S. FDA for PAXLOVID Business Wire
03:58AM	Walgreens Boots, RH, JetBlue Fall Premarket; Constellation Brands Rises Investing.com
Jun-29-22 09:41PM	Pfizer Says Its New Vaccine is Effective Against Omicron Investopedia
06:38PM	U.S. Agrees to Pay $3.2 Billion for More Pfizer Covid Vaccines The Wall Street Journal
05:45PM	Pfizer (PFE) Gains As Market Dips: What You Should Know Zacks
05:25PM	UPDATE 2-Pfizer signs new $3.2 bln COVID vaccine deal with U.S. government Reuters
05:03PM	U.S. to pay $3.2 billion to Pfizer, BioNTech for more COVID-19 vaccines for fall MarketWatch
04:57PM	Pfizer signs $3.2 bln deal with U.S. government for COVID vaccine doses Reuters
04:45PM	Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine Business Wire
04:13PM	Novavax Outperforms Rivals After FDA Panel Backs Updated Covid Shots Investor's Business Daily
01:50PM	Top 10 Dividend Stocks to Buy According to James Katzs Humankind Investments Insider Monkey
10:42AM	Pfizer (PFE) Discloses Autoimmune Drug Deal With Priovant Zacks
10:26AM	FDA recommends updating COVID booster shots to fight Omicron Yahoo Finance Video
09:10AM	Top 10 Stock Picks of Mika Toikkas AlphaCrest Capital Insider Monkey
09:09AM	UPDATE 1-BioNTech, Pfizer to start testing universal vaccine for coronaviruses Reuters
08:44AM	FDA Panel Recommends Modifying COVID Jabs to Target Omicron Zacks
08:00AM	BioNTech, Pfizer to starting testing universal coronavirus vaccine in H2 Reuters
07:44AM	FDA Advisers Recommend Updating Covid-19 Boosters for Omicron Component Barrons.com
05:27AM	EU's von der Leyen can't find texts with Pfizer chief on vaccine deal -letter Reuters
01:23AM	These companies' values soared during the pandemic. Here's how they are faring in 2022's turbulent market. American City Business Journals
Jun-28-22 06:22PM	FDA Advisers Recommend Modifying Covid-19 Boosters to Target Omicron The Wall Street Journal
05:03PM	FDA advisers say the U.S. needs updated COVID-19 boosters to fight omicron MarketWatch
04:02PM	Pfizer, Moderna to be ready with BA.1-specific COVID boosters Reuters
03:39PM	Novartis Will Cut 8,000 Jobs Under CEOs Shake-Up Plan Barrons.com
01:33PM	J&J does not plan to update its COVID-19 vaccine MarketWatch
09:58AM	UPDATE 3-U.S. FDA advisers recommend change to COVID vaccine composition for fall Reuters
09:42AM	Company News for Jun 28, 2022 Zacks
09:40AM	Roivant, Pfizer Unveil Latest Spinout Focused On Autoimmune Diseases Benzinga
08:30AM	U.S. FDA advisers meet to discuss design of future COVID vaccines Reuters
06:27AM	Roivant, Pfizer unveil Priovant Therapeutics focused on autoimmune disease treatments, Roivant stock surges MarketWatch
06:00AM	Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus GlobeNewswire
06:00AM	Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus Business Wire
Jun-27-22 12:09PM	States could ban abortion pill for Medicaid enrollees, experts say Yahoo Finance
11:52AM	Pfizer booster improved to fight omicron, as hospitalizations rise to 3-month high MarketWatch
11:01AM	Investors are Watching These 10 Biotech Stocks Insider Monkey
10:53AM	How Pfizer Plans to Unlock Another Mass-Market Vaccine Motley Fool
10:46AM	Pfizer's (PFE) Omicron-Based COVID Shot Betters Immune Response Zacks
10:44AM	I Dare All Meme Stock Maniacs: Cliff Asness Short Position on AMC and His Top 10 Picks Insider Monkey
09:07AM	Is Pfizer Inc. (NYSE:PFE) Popular Amongst Institutions? Simply Wall St.
08:49AM	Pfizer/BioNTech's Updated Omicron-Based COVID-19 Shots Show Improved Response Against Variant Benzinga
07:03AM	No Government Money, No Problem for Moderna and Pfizer The Wall Street Journal
06:33AM	The Russian Default Is Less Worrisome Than It Appears. Keep Watching Oil. Barrons.com
06:17AM	Coronavirus tally: Pfizer says updated COVID-19 booster is better against omicron, as cases top 100,000 again MarketWatch
06:00AM	Could This Be Moderna's Ticket to Long-Term Success? Motley Fool
03:00AM	FDA Panel Will Weigh In on Covid Boosters for This Fall. Whats at Stake. Barrons.com
Jun-25-22 05:13PM	Birth Control Stocks May Benefit From the Reversal of Roe v. Wade TheStreet.com
04:06PM	Pfizers Omicron-Targeting Covid-19 Vaccines Generate Stronger Immune Response The Wall Street Journal
11:17AM	Pfizer says updated COVID-19 booster can provide more protection against super-contagious omicron MarketWatch
11:02AM	Pfizer and BioNTech Say Their Updated Boosters Provide More Protection Against Omicron Barrons.com
10:57AM	BioNTech/Pfizer say Omicron-targeting boosters elicit strong immune response Financial Times

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DAMICO JENNIFER B.	SVP & Controller	Jun 07	Sale	53.96	4,218	227,603	10,846	Jun 08 04:43 PM
DAMICO JENNIFER B.	SVP & Controller	May 16	Sale	50.50	4,000	202,000	15,064	May 17 07:48 AM
SAHNI PAYAL	Executive Vice President	May 13	Sale	49.84	1,408	70,175	17,372	May 16 09:23 PM
Carapezzi William R JR	Executive Vice President	May 12	Sale	50.00	32,908	1,645,400	38,146	May 13 05:38 PM
LANKLER DOUGLAS M	Executive Vice President	May 12	Sale	49.41	38,273	1,891,069	78,803	May 13 05:19 PM
Dolsten Mikael	President R&D	May 11	Sale	49.32	63,902	3,151,547	333,342	May 12 04:34 PM
Dolsten Mikael	President R&D	Mar 03	Option Exercise	31.83	102,460	3,261,036	396,578	Mar 04 04:13 PM
DAMELIO FRANK A	Executive Vice President	Feb 26	Option Exercise	25.60	127,160	3,255,296	649,918	Mar 01 05:55 PM
SUSMAN SALLY	Executive Vice President	Feb 26	Option Exercise	25.60	63,580	1,627,648	172,880	Mar 01 05:55 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 26	Option Exercise	25.60	9,713	248,653	26,120	Mar 01 04:02 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 26	Option Exercise	25.60	77,709	1,989,350	174,507	Mar 01 04:03 PM
McDermott Michael	Executive Vice President	Feb 26	Option Exercise	25.60	12,340	315,904	83,530	Mar 01 04:03 PM
Carapezzi William R JR	Executive Vice President	Feb 26	Option Exercise	25.60	21,193	542,541	87,363	Mar 01 04:03 PM
Carapezzi William R JR	Executive Vice President	Feb 23	Option Exercise	27.34	25,632	700,779	82,914	Feb 25 05:06 PM
SAHNI PAYAL	Executive Vice President	Feb 23	Option Exercise	27.34	13,884	379,589	29,391	Feb 25 06:27 PM
SUSMAN SALLY	Executive Vice President	Feb 23	Option Exercise	27.34	76,895	2,102,309	166,470	Feb 25 06:29 PM
Hwang Angela	Group President	Feb 23	Option Exercise	27.34	21,359	583,955	21,359	Feb 25 06:10 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 23	Option Exercise	27.34	115,342	3,153,450	181,659	Feb 25 06:20 PM
DAMELIO FRANK A	Executive Vice President	Feb 23	Option Exercise	27.34	153,789	4,204,591	636,977	Feb 25 06:04 PM
JOHNSON RADY A	Executive Vice President	Feb 23	Option Exercise	27.34	35,457	969,394	91,301	Feb 25 06:17 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 23	Option Exercise	27.34	11,748	321,190	21,668	Feb 25 05:46 PM
Dolsten Mikael	President R&D	Dec 17	Option Exercise	30.17	71,187	2,147,712	351,637	Dec 21 06:31 PM
BOURLA ALBERT	Chairman & CEO	Dec 17	Option Exercise	26.73	123,055	3,289,547	246,444	Dec 21 06:03 PM
JOHNSON RADY A	Executive Vice President	Dec 03	Sale	53.42	19,000	1,015,042	55,844	Dec 06 05:18 PM
MACKENZIE ALEXANDER R	Executive Vice President	Dec 02	Sale	54.26	41,360	2,244,194	87,280	Dec 06 05:18 PM
SUSMAN SALLY	Executive Vice President	Nov 26	Sale	54.52	44,308	2,415,578	89,575	Nov 30 04:30 PM
LANKLER DOUGLAS M	Executive Vice President	Nov 26	Sale	54.37	40,000	2,174,786	66,317	Nov 30 04:30 PM
Hwang Angela	Group President	Nov 12	Sale	49.60	26,170	1,298,002	1	Nov 15 05:32 PM
Dolsten Mikael	President R&D	Nov 11	Option Exercise	25.13	199,548	5,014,926	339,506	Nov 15 05:40 PM
Dolsten Mikael	President R&D	Nov 11	Sale	50.29	59,664	3,000,647	279,842	Nov 15 05:40 PM
YOUNG JOHN D	Group President	Nov 11	Sale	50.06	150,000	7,508,732	312,704	Nov 12 06:08 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 13	Sale	48.30	1,661	80,226	9,769	Aug 16 08:12 PM
DAMICO JENNIFER B.	SVP & Controller	Jul 30	Sale	42.86	2,500	107,150	11,430	Aug 02 07:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience